Propanc Biopharma clears path for Phase 1b clinical study
Propanc Biopharma (PPCB) clears the path for a world-first Phase 1b clinical study of a cancer therapy,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.